iifl-logo

Sagility Ltd Management Discussions

Add as a Preferred Source on Google
₹45.15
(2.87%)
Nov 18, 2026|03:59:37 PM

Sagility Ltd Share Price Management Discussions

INDUSTRY OVERVIEW

The United States healthcare market remains the largest and among the most complex in the world, shaped by sustained demand, expanding coverage needs, rising clinical and administrative intensity, and continued pressure to improve affordability, access, and outcomes. According to the Centers for Medicare & Medicaid Services, national health expenditure is projected to reach 20.3% of GDP by 2033, up from 17.6% in 2023, underscoring both the scale of the market and the urgency of improving how healthcare is administered, managed, and delivered.

Despite this scale, the U.S. healthcare system continues to face persistent inefficiencies. Administrative fragmentation, disconnected workflows, rising operating costs, and uneven consumer and patient experiences continue to create friction across the ecosystem. These challenges are intensifying as payers and providers manage higher volumes, more complex member and patient journeys, and increasing expectations for speed, accuracy, responsiveness, and personalization.

STRUCTURAL DRIVERS OF DEMAND AND TRANSFORMATION OF CARE DELIVERY

The healthcare industry continues to be shaped by several long-duration forces that are increasing both demand and complexity, while also changing how care is financed, delivered, and experienced.

One of the most significant of these is demographic change. The U.S. Census Bureau has identified 2030 as a demographic turning point, when all baby boomers will be over age 65 and one in five U.S. residents will be of retirement age. Older populations typically require more frequent and more complex healthcare interactions and are more likely to live with multiple chronic conditions, increasing the need for coordinated care, longitudinal engagement, utilization management, and more sophisticated operational support.

The burden of chronic disease remains another defining driver. Diabetes, cardiovascular conditions, respiratory illness, and other long-duration conditions continue to account for a significant share of utilization and healthcare spending. This is reinforcing the importance of prevention, risk stratification, care coordination, and population-level interventions across the healthcare ecosystem.

Coverage dynamics are adding further complexity across the healthcare ecosystem. While Medicare Advantage 1 enrolment continues to increase, growth is maturing and profitability pressures are intensifying. Plans are responding by investing in AI, automation, operational efficiency, Stars performance, utilization management, payment integrity, and member experience to protect margins while managing an increasingly complex and highly regulated population. At the same time, Medicaid programs are undergoing significant change as states continue post-pandemic eligibility redeterminations while preparing for funding, eligibility, and operational changes stemming from the One Big Beautiful Bill Act (OBBB). In parallel, the expiration of enhanced Affordable Care Act Marketplace premium subsidies and new marketplace enrollment requirements are expected to drive shifts in Exchange enrollment and member affordability. Together, these policy changes are increasing membership volatility across Medicaid and Exchange populations, requiring health plans to strengthen capabilities across enrollment, eligibility, claims, billing, payment integrity, and member engagement while maintaining operational precision in an increasingly complex regulatory environment.

At the same time, consumer expectations are changing. Patients and members increasingly expect convenience, transparency, speed, and personalization in healthcare interactions. The growth of digital channels and self-service expectations is accelerating the need for engagement models that are more responsive, experience-led, and integrated across the healthcare journey.

Care delivery itself is also evolving. The industry continues to move toward value-based models that place greater emphasis on outcomes, quality, and cost efficiency. In parallel, care is increasingly shifting toward lower-cost and more accessible settings, including outpatient, ambulatory, virtual, and home-based environments. These transitions are increasing the need for stronger coordination across administrative, clinical, and financial workflows.

These structural drivers underscore the need for operating models that are integrated, scalable, and capable of performing consistently in complex healthcare environments. 1 https://www.kff.org/medicaid/medicaid-what-to-watch-in-2026

The competitive landscape is also evolving. Healthcare organizations are moving away from fragmented vendor relationships and isolated point solutions toward more integrated partners that can combine domain expertize, workflow transformation, analytics, AI enablement, and accountable execution. In parallel, technology-native firms, platform providers, and diversified services players are increasing their presence across the ecosystem, raising the standard for speed, interoperability, and measurable outcomes. These factors are shifting the basis of competition from scale alone to relevance, integration, and the ability to deliver sustained value across end-to-end workflows.

Sagilitys strategy is aligned to these shifts. We continue to deepen our capabilities across payer and provider workflows, including enrolment, claims, payment integrity, care management, revenue cycle support, and engagement operations, in order to help clients navigate rising complexity with greater precision, efficiency, and accountability.

We believe the next phase of growth in healthcare operations will be defined by the ability to combine domain expertize, decision intelligence, and execution into a single operating model and translate that into measurable outcomes.

Against this backdrop, our priorities are focused and consistent.

• Scaling technology and AI-led, outcome-based engagements across our client base, aligning more directly with the business impact we deliver

• Expanding connected lifecycle operating models , including Synchrony, across administrative, clinical, and financial operations.

At the same time, Sagility is expanding into the mid- and small-market segment , leveraging our BroadPath acquisition. We will continue to invest in capabilities that strengthen our long-term structural advantage , while pursuing targeted acquisitions that deepen our domain expertize, expand our technology and AI capabilities, and reinforce our positioning in the market. In FY 2027, we will scale with greater emphasis on execution consistency, client outcomes and operational discipline .

ARTIFICIAL INTELLIGENCE AS A CORE TRANSFORMATION LAYER

Artificial intelligence is rapidly emerging as a foundational transformation layer across healthcare operations. Its value lies not only in automation, but in improving how decisions are made, how workflows are orchestrated, and how complex administrative and clinical support processes are executed with greater speed, consistency, and intelligence. In a sector defined by fragmentation, regulatory complexity, and high consequence decisions, AI is increasingly becoming central to how healthcare organizations improve performance while managing risk.

The next wave of impact will come from embedding intelligence directly into operational workflows rather than treating AI as a standalone tool. This includes intelligent triage, guided decision support, workflow prioritization, document and data interpretation, exception management, and agent-assisted execution across areas such as claims, payment integrity, care management, revenue cycle, contact centre operations, and provider enablement. As these capabilities mature, organizations will increasingly shift from isolated pilots toward enterprize-scale deployment that delivers measurable business outcomes.

Healthcare, is not an environment where generic automation alone is sufficient. The operating context requires domain specificity, regulatory awareness, auditability, and the ability to combine machine intelligence with human judgment. AI adoption in this sector therefore favours models that are deeply embedded within healthcare workflows and supported by clinical, operational, and compliance expertize. This creates significant differentiation for organizations that can responsibly operationalize AI in a way that improves cost, quality, experience, and performance without compromising control. For Sagility, AI is not a parallel capability. It is increasingly embedded into the operating model itself. Our approach combines healthcare domain expertize, workflow understanding, platform enablement, and human-in-the-loop execution so that intelligence is applied where it can improve decisions and outcomes. We believe this will define and transform the next generation of healthcare operations. Driving ROI from AI Through Domain-Led Execution: Sagilitys approach to AI is fundamentally anchored in domain strategy rather than a platform-led lens. Sagility focuses on embedding AI into healthcare workflows where impact can be directly measured, moving beyond isolated automation to driving meaningful business outcomes.

SAGILITYS UNIQUE POSITIONING DELIVERING

DIFFERENTIATED IMPACT

We operate at the intersection of healthcare domain depth, operational execution, and technology and AI-led transformation. Our positioning is shaped by the needs of a market that increasingly demands more than capacity augmentation or fragmented point solutions. Clients are looking for partners who understand the complexity of healthcare workflows, can execute at scale, and can translate technology and AI into measurable business outcomes. We believe Sagility is well positioned to play that role.

Our differentiation begins with deep specialization in healthcare. We serve complex payer and provider workflows where accuracy, regulatory discipline, and operating precision matter. This domain intensity allows us to engage in areas that are difficult to commoditize and increasingly important to clients, including payment integrity, utilization management, care support, enrolment and billing, revenue cycle operations, and member and patient engagement. It also creates the foundation for more effective deployment of AI, analytics, and platform-led solutions because the intelligence is grounded in healthcare context rather than applied generically.

We are also evolving beyond traditional delivery constructs toward a more connected operating model. Through integrated workflow orchestration, platform enablement, AI-augmented execution, and outcomes-based engagement structures, we are helping clients move from siloed operations to more intelligent and accountable models of performance. This reflects The Companys broader ambition to serve as the decision intelligence and outcomes layer for healthcare operations.

Sagilitys market opportunity is reinforced by the way the ecosystem itself is changing. As payers, providers, and adjacent healthcare stakeholders pursue tighter integration, platform-based coordination, and greater accountability for outcomes, the demand for operating partners with deep healthcare specialization and transformation capability is increasing. We believe this favours organizations that can combine execution depth with workflow redesign, intelligence, and scalable delivery.

ENTERING FY 2027: SCALING WHAT WORKS

As Sagility enters FY 2027, the focus will remain on scaling the capabilities and engagement models that are already demonstrating relevance in the market. This includes expanding technology and AI-led and platform-enabled solutions, deepening outcome-based partnerships, extending integrated lifecycle models such as Synchrony, and broadening our reach across client segments through assets such as BroadPath. We will continue to invest in the capabilities that strengthen long-term differentiation, while remaining disciplined in how we allocate capital and prioritize growth.

Sagilitys objective is not simply to grow with the market, but to help shape the next model of healthcare operations through deeper integration of expertize, intelligence, and execution. This focus positions Sagility to create sustained impact for clients while strengthening the resilience and quality of our own growth trajectory.

Looking ahead, Sagility expects the market to continue shifting toward AI-enabled, platform-supported, and more integrated operating models. At the same time, clients will place greater emphasis on partners that can help them manage complexity, improve experience, reduce administrative waste, and create measurable financial and operational outcomes at scale.

FINANCIAL PERFORMANCE

FY 2026 marked a year of robust growth and improved profitability despite a challenging and evolving healthcare environment. We delivered robust performance, reflecting disciplined execution, deep client relevance, and the resilience of its operating model.

Revenue from operations for the year stood at Rs. 71,929 Million (US$ 814 Million), representing year-on-year growth of 29.1% in Rs. terms and 23.6% in constant currency. This growth was broad-based, driven by continued expansion within existing relationships as well as momentum in new client acquisition. The Companys top 5 clients grew 16.7% year-on-year, underscoring our ability to advance our relationships and scale engagements in complex, high-value workflows. Concentration in the top clients reduced in FY26 as we expanded our portfolio with new clients and advanced our relationship with smaller, yet important, existing clients. The expanded presence of small and mid-segment accounts has created resilience and balance in Sagilitys revenue profile over time. Sagility added 17 new clients during the year,

Partnership Models
Enablement Partner Domain experts Outcomes
Client-led Tech \u2022 Analytics \u2022 Speed to balue
\u2022 Use Cases \u2022 Member & Provider satisfaction
\u2022 Workflow creation
Implementation Partner Domain & Technical expertise to
Shared Ownership \u2022 Design \u2022 Speed to balue
\u2022 Build \u2022 Member & Provider satisfaction
\u2022 Integrate
\u2022 Deploy
Managed Solution Partner End-to-end GenAI Solution with Platform Tools
Sagility-Led \u2022 Domain intelligence \u2022 Outcome ownership
Workflow Models \u2022 Cost Savings
\u2022 Expert Teams for Design, Buid, Deploy & Operate

including regional Blues plans, with early traction in the mid- and small-market segments, providing a robust foundation for diversification and future growth. Organic growth, excluding the impact of BroadPath, remained healthy at 20.1% in Rs. terms and 15.0% in constant currency, reflecting the underlying intensity of demand and execution. Profitability remained healthy alongside revenue growth. Adjusted EBITDA for FY 2026 stood at Rs. 18,200 Million (US$ 206 Million), translating to a margin of 25.3%. This performance was supported by operating leverage from scale, continued focus on execution efficiency, and an increasing mix of transformation-led and outcome-based engagements. Sagilitys solution portfolio, particularly its Synchrony suite, continued to gain traction as clients increasingly prioritized measurable outcomes and integrated managed services. Sagilitys revenue mix remained rooted in its core payer segment, which contributed 89.7% of revenues, while the provider segment accounted for 10.3%. This split reflects Sagilitys deep specialization in healthcare payer operations, while also highlighting the opportunity to expand further in provider-led engagements. Strategic investments during the year further improved company capabilities, complemented by the addition of BroadPath earlier, which continues to prove its value by enhancing The Companys ability to support member-facing and seasonal operations, particularly during peak enrolment cycles.

Sagility also continued to invest in its delivery capacity, with employee strength reaching 46,860 as of 31 st March 2026. Overall, the financial performance in FY 2026 reinforces Sagilitys positioning as a healthcare-focused operations partner that combines domain expertize, technology-led solutions, and scalable execution to deliver consistent growth and profitability.

RESULT OF OPERATIONS BASED ON CONSOLIDATED FINANCIAL RESULTS

The table below shows Sagilitys consolidated income and expenses for year ended 31 st March 2026 and 31 st March 2025.

Particulars For the year ended 31 st March 2026 For the year ended 31 st March 2025
(in Rs. Million) % of Revenue from Operations (in Rs. Million) % of Revenue from Operations
Income
Revenue from operations 71,928.51 100.00% 55,699.18 100.00%
Expenses
Employee benefits expense 45,102.76 62.70% 34,989.01 62.82%
Other expenses 9,223.00 12.82% 7,731.35 13.88%
Total expenses 54,325.76 75.53% 42,720.36 76.70%
Other income 979.79 1.36% 563.08 1.01%
Earnings before interest expense, taxes, depreciation and amortisation 18,582.54 25.83% 13,541.90 24.31%
Finance costs 991.62 1.38% 1,271.03 2.28%
Depreciation and amortisation expense 4,873.70 6.78% 4,668.56 8.38%
Profit before exceptional items 12,717.22 17.68% 7,602.31 13.65%
Less: Exceptional item 328.23 0.46%
Profit before tax for the year 12,388.99 17.22% 7,602.31 13.65%
Tax expense:
Current tax 3,464.92 4.82% 2,628.76 4.72%
Deferred tax -323.61 -0.45% -417.68 -0.75%
Total tax expense 3,141.31 4.37% 2,211.08 3.97%
Profit for the year 9,247.68 12.86% 5,391.23 9.68%

Revenue from Operations

Revenue from operations increased by 29.1% to 71,929 Million for FY 2026 from Rs. 55,699 Million for FY 2025. This increase was due to growth from existing clients, new deal wins and full year impact of acquisition of the of BroadPath.

Revenue growth in reported terms include the impact of currency fluctuations. We, therefore, additionally report the revenue growth in constant currency terms. Our Revenues from Operations in FY 2026 in constant currency terms was US $814.0 Million a 23.6% increase over FY 2025 (US $658.3 M).

Further, Sagility also added 17 new clients in the FY 2026, which also contributed to the increase in our revenue from operations. Revenue from our payer clients increased by 29.6% while revenue from our provider clients increased by 25.6%. Revenue from operations from our top five clients increased by 16.7% to Rs. 50,606 Million for FY 2026 from Rs. 43,370 Million for FY 2025. Below is a table showing revenues from our top 3, top 5, and top 10 client groups, both in absolute terms and as a percentage of total revenue.

Particulars For the year ended 31 st March 2026 For the year ended 31 st March 2025
(in Rs. Million) % of Revenue for operation (in Rs. Million) % of Revenue for operation
Top 3 Client % 43,076.76 59.89% 36,847.71 66.16%
Top 5 Client % 50,606.42 70.36% 43,370.27 77.87%
Top 10 Client % 60,364.95 83.92% 50,423.31 90.53%

* Clients comprise client entities together with their affiliates.

Other Income

Other income primarily comprises net foreign exchange gains, income from investments and gains arising on lease modifications. Increase over FY 2026 is due to depreciation of the Indian rupee and Philippines peso against U.S. dollar.

Employee Benefit Expenses

Employee benefit expenses excluding share-based payment awards increased to 62.5% of revenue in FY 2026 from 60.8% in FY 2025. This increase is attributed to higher onshore mix and full-year impact of BroadPath acquisition.

Employee benefit expenses including share-based payment awards as a percentage of revenue stood at 62.7% in FY 2026 vs 62.8% in FY 2025.

Other Expenses

Other expenses primarily consist of legal and professional fees, software subscription charges, travel, communication, power and fuel, marketing, recruitment and short-term rent expenses etc. In FY 2026, other expenses decreased to 12.8% from 13.9% in FY 2025. Decrease is majorly on account of operational improvements and favourable foreign exchange movements.

Finance Costs

Finance costs include interest on promoter debt and lease liabilities. The expense decreased as the borrowings came down because of repayment of promoter debt.

Depreciation and Amortization

Depreciation and amortization expense increased marginally to Rs. 4,874 Million in March 2026 from Rs. 4,668 Million in Mar 2025.

The increase is primarily attributable to full year impact of the amortization of intangible assets created in relation to acquisition of BroadPath.

Exceptional Item

Exceptional Items represents one time impact of employee benefit obligations arising from the New Labour Codes introduced by Government of India effective 21 st November 2025.

Sagility has undertaken salary restructuring exercise in compliance with the New Labour Codes which has resulted in an increase in the provision for gratuity and leave encashment.

Taxes

Tax expenses for FY 2026 is Rs. 3,141 Million (FY 2025: Rs. 2,211 Million). Increase is tax expense is primarily attributable to higher profits netted-off with lower books to tax adjustment. FY 2025, had higher books to tax adjustment on account of onetime increase in the fair value of share-based payment awards which was a non-deductible expense for income tax purposes.

DISCUSSION ON FINANCIAL POSITION ON CONSOLIDATED FINANCIAL RESULTS

Equity Share Capital

We have one class of equity shares with the authorized share capital at Rs. 100,000 Million with 10,000 Million equity shares of 10 each. The paid-up share capital as at FY 2026 stands at Rs. 46,793 Million (FY 2025: Rs. 46,793 Million).

There was no increase in share capital during FY 2026.

Other Equity

As of March 2026, total other equity is Rs. 49,798 Million (March 2025: Rs. 36,567 Million) with an increase of Rs. 13,231 Million over FY 2025.

The increase in other equity is attributable to profits earned during the year and impact of the exchange difference.

Borrowings

As of March 2026, unsecured borrowings were Rs. 5,776 Million (including accrued interest of Rs. 106 Million) reduced from 8,170 Million (including accrued interest of Rs. 149 Million) in March 2025. Decrease in borrowing is mainly attributed to repayment of debt to Sagility BV (Promoter and Holding company of Sagility Limited).

Deferred Tax Assets and Liabilities

As of March 2026, the Group had net deferred tax liability of 2,697 Million (31 st March 2025 - Rs. 2,941 Million) comprising of Rs. 1,514 Million (31 st March 2025 - Rs. 1,338 Million) of deferred tax assets and Rs. 4,211 Million (31 st March 2025 - Rs. 4,279 Million) of deferred tax liability.

Increase in deferred tax assets during the year is primarily attributable to the recognition of deferred tax assets on derivative liabilities, partially offset by the reversal of deferred tax assets arising from a reduction in the tax base of intangible assets due to amortization during the year.

Decrease in deferred tax liability during the year is primarily attributable to the recognition of deferred tax assets arising from employee benefit provisions, partially offset by an increase in deferred tax liability on intangible assets.

Lease Liabilities

Lease liabilities for Sagility as of March 2026, were Rs. 5,330 Million (March 2025 - Rs. 5,850 Million). We added 4 new sites and consolidated 6 sites during the year with 31 sites under lease at year end.

Provisions

Provisions consist of employee benefit obligations which includes gratuity, leave encashment, and pension (for Philippines). These liabilities are determined based on the actuarial valuation. As of March 2026, provision is Rs. 3,524 Million (March 2025: Rs. 2,689 Million). Increase in employee benefit obligation is attributable to increase in head count and one time impact of the New Labour Codes in India. Sagility has restructured the salary effective 21 st November 2025 in compliance with the New Labour Codes in India

Financial (Including Trade Payable) and Other Liabilities

Sagilitys total other financial (including trade payable) and other liabilities as of March 2026 is Rs. 10,338 Million (March 2025: Rs. 5,754 Million). Increase in financial liabilities is primarily on account of salary payable, derivative liabilities, capital creditors, and discount payable to customer. Increase in salary payable is due to change in company appraisal cycle to April - March from January - December.

Tax Assets / Liabilities

These comprise of tax amounts recoverable from and payable to government authorities. It includes Rs. 70 Million paid under protest to statutory authorities against the tax demands.

Goodwill

Sagility was formed by the acquisition of healthcare business from Hinduja Global Solutions (HGS) in January 2022 by Sagility B.V (earlier known as Betaine B.V). The excess of purchase consideration over fair value of assets was allocated to Goodwill and Other Intangible Assets. Goodwill from the acquisition of the healthcare business from HGS constitute to 51,701 Million; Additional goodwill of Rs. 4,887 Million was due to acquisitions (DCI, BirchAI, and BroadPath) made by Sagility in fiscal years 2024 and 2025 and balance Rs. 7,463 Million is due to forex movements.

Goodwill and intangibles are tested for impairment in accordance with Ind AS, and that management has assessed the recoverability.

Property Plant and Equipment

Our property, plant, and equipment primarily consist of computer equipment and leasehold improvements. During the year, the net block increased primarily due to the acquisition of assets, mainly computers and leasehold improvements. Fixed assets are being amortized over their useful life.

Other Intangible Assets

As covered above under goodwill. Intangible primarily arises from the acquisition of healthcare business from HGS in January 2022. Additions to Intangibles are on account of acquisitions made by Sagility in fiscal years 2024 and 2025. During the year, the net block increased primarily due to the foreign exchange movements and Intangible assets under development.

Other Financial Assets

Other financial assets comprise security deposits mainly towards lease premises and loans to employees.

Investments

Investments comprise of investment in short-term mutual funds. As of Mar26, Investment in mutual funds in India & USA is Rs. 3,074 Million and Rs. 285 Million respectively. These are classified as Fair value through profit and loss (FVTPL).

Other Assets

Other assets majorly consist of balance with government authorities, prepaid expenses, supplier and employee advances. During the year, decrease is primarily on account of contract assets.

Trade Receivables

Days Sales Outstanding (DSO) was 87 days for the year ended 31 st March 2026, compared to 76 days in the previous year. DSO is calculated considering both Unbilled Revenues and Trade Receivables.

During the year, a discount amounting to Rs. 860 Million was reclassified from trade receivables to other financial liabilities, which contributed to an increase in DSO.

Cash and Bank Balances

Our cash and cash equivalents comprise of deposits with banks which can be withdrawn at any point of time without prior notice or penalty on principal.

Cash Flows Based on Consolidated Financial Results

The following table summarizes our cash flows data for the periods indicated:

Particulars 31 st March 2026 31 st March 2025
Net cash flow from operating activities 12,030 12,141
Net cash flow used in investing activities (7,107) (9,642)
Net cash flow used in financing activities (5,014) (2,561)
Cash and cash equivalents at the beginning of the year 3,438 3,441
Foreign exchange gain on translating Cash and cash equivalents 233 58
Cash and cash equivalents at the end of the year 3,579 3,438

Operating Activities

Our cash flows from operating activities are broadly flat in FY 2026 compared to FY 2025 due to increase in DSO and higher tax outflows. We had received tax refunds of Rs. 621 Million for prior period in FY 2025.

Investing Activities

Cash flows from in investing activity have decreased in FY 2026 as FY 2025 cash flows included the impact of the Purchase consideration for BroadPath acquisition and payment of the pending purchase consideration for acquisition of health care business from HGS in January 2022.

Financing Activities

Net cash flows used in financing activities for FY 2026 is Rs. 5,014 Million which is majorly towards repayment of borrowings (including interest) to Sagility BV for Rs. 2,937 Million, repayment of lease liabilities (including interest) for Rs. 1,843 Million and payment of interim dividend for Rs. 234 Million.

Increase in cash flow from financing activities in FY 2026 over FY 2025 is due to the impact of inflow from Sagility B.V. (promoter) for 3,708 Million through share issuance in FY 2025.

KEY FINANCIAL RATIOS BASED ON CONSOLIDATED FINANCIAL RESULTS

Particulars 31 st March 2026 31 st March 2025
Debtors\u2019 turnover* (x) 7.21 6.95
Current ratio (x) 1.55 1.67
Debt-equity ratio (times) 0.11 0.17
Interest coverage ratio (x) 13.82 6.98
EBITDA margin (%) 25.8% 24.3%
PAT margin (%) 12.9% 9.7%
Earnings per share () 1.98 1.17
Return on Net Worth^ (%) 10.3% 7.3%
Adjusted EBITDA** margin (%) 25.3% 26.4%
Adjusted PAT*** margin (%) 15.7% 14.6%
Adjusted Return on Capital Employed # (%) 58.9% 54.9%

*Debtors turnover represents revenue to average billed receivables

^Return on net worth is calculated by dividing the profit after tax by the average of the opening and closing total equity balance.

**Adjusted EBITDA represents EBITDA adjusted for post combination expenses in relation to earnouts payable under the acquisition agreements and share-based payment awards and excludes other income

***Adjusted PAT represents profit/(loss) adjusted for post combination expenses in relation to earnouts payable under acquisition agreements, share-based payment awards; amortization of other intangible assets acquired pursuant to business combinations, and for the tax impact of each of the adjustments

# The Adjusted Return on Capital Employed (ROCE) is calculated by taking the Adjusted Profit After Tax (PAT) plus interest cost, divided by the adjusted capital employed. The adjusted capital employed is determined as the total assets excluding goodwill and intangible assets, minus current liabilities.

SIGNIFICANT CHANGES IN KEY FINANCIAL RATIOS

Debtors Turnover (7.21x vs 6.95x)

The improvement in debtor turnover is due to currency movements.

Current Ratio (1.55x vs 1.67x)

The decline in current ratio is primarily attributable to the reclassification of borrowings from non-current to current and an increase in derivative liabilities. The borrowings under current liabilities as of March 2026 and March 2025 amounted to Rs. 5,775.7 Million and Rs. 2,499.1 Million respectively. As of March 2026, the scheduled repayments due within the next financial year have increased, resulting in a higher current liability and consequently impacting the current ratio.

Debt-Equity Ratio (0.11x vs 0.17x)

The debt-equity ratio improved further on account of continued deleveraging, supported by repayment of borrowings and a stronger equity base.

Interest Coverage Ratio (13.82x vs 6.98x)

Interest coverage ratio improved substantially, reflecting higher EBITDA and lower interest expense following debt reduction, strengthening Sagilitys debt servicing capacity.

EBITDA Margin (25.8% vs 24.3%)

The increase in EBITDA margin was supported by higher forex gains and lowering Stock Appreciation Rights (SAR) costs.

PAT Margin (12.9% vs 9.7%)

PAT margin improved significantly driven by higher EBITDA percentage, lower interest costs and lower depreciation and amortization percentage.

Earnings Per Share ( 1.98 vs 1.17)

The significant increase in EPS is driven by revenue growth and increase in PAT margins.

Return on Net Worth (10.3% vs 7.3%)

Return on Net Worth increased significantly driven by increase in profit after tax, though remains moderated by relatively higher equity base including goodwill and intangibles from past acquisitions.

Adjusted EBITDA Margin (25.3% vs 26.4%)

The marginal decline in Adjusted EBITDA margin in March 2026 is attributed to higher onshore mix and full year impact of BroadPath acquisition.

Adjusted PAT Margin (15.7% vs 14.6%)

Adjusted PAT margin improved, driven by increase in other income, forex gains and lower interest expenses.

Adjusted Return on Capital Employed (58.9% vs 54.9%)

Increase in adjusted ROCE is due to improvement in profitability

RISK MANAGEMENT

Sagilitys Board of Directors has overall responsibility for the establishment and oversight of Sagilitys risk management framework. The Companys risk management policies are established to identify and analyse the risks faced by The Company, to set appropriate risk limits and controls and to monitor and mitigate risks. Risk management policies and systems are reviewed regularly to reflect changes in market conditions and The Companys activities. Sagility has a Risk Management Committee chaired by an Independent Director, which assists the Board in monitoring and overseeing implementation of the risk management policy, including evaluating the adequacy of risk management systems and such other functions as mandated under the SEBI Listing Regulations and as the Board may deem fit from time to time. The composition, detailed terms of reference of the Committee and attendance at its meetings are provided as part of the Corporate Governance Report. Sagilitys Board monitors compliance with The Company risk management policies and procedures and reviews the adequacy of the risk management framework in relation to the risks faced by The Company. At present, in the opinion of the Board of Directors, there are no risks which may threaten the existence of The Company. The Risk Management policy is available on the website of Sagility at https://Sagility.com/wp-content/uploads/2026/02/ Sagility-risk-management-policy.pdf .

RISK MITIGATION SUMMARY

Risk Theme Description Mitigation
Geo-Political and Sector Risks \u2022 Sagility derives its entire revenue from the U.S. healthcare industry, exposing it to regulatory, economic, and outsourcing-related developments in that market. \u2022 To mitigate these risks, we are continuing to deepen and diversify our presence across the U.S. healthcare ecosystem by serving both Payer and Provider segments. In parallel, we are expanding into adjacent, higher-value areas such as clinical services and pharmacy benefit management, strengthening our ability to support clients across a broader range of healthcare operations.
\u2022 In addition, continued focus on regulatory compliance, information security, delivery resilience and client-specific operating models helps Sagility respond effectively to healthcare policy, market and outsourcing-related changes.
\u2022 Sagility operates delivery centres across multiple geographies, including onshore and nearshore locations in the U.S., Jamaica and Colombia, as well as offshore centres in India and the Philippines. This geographically diversified delivery footprint reduces dependence on any single country and helps mitigate country-specific political, regulatory, talent and business-continuity risks.
\u2022 Sagility has negligible dependency on H1B visas issued by the U.S. Government. Throughout the year, it actively monitors U.S. political and legislative developments including proposed measures such as the HIRE Act and state-level anti-outsourcing bills, through its dedicated tax and legal & compliance teams, as well as third-party consultants. For any high-impact legislative changes that could affect operations, Sagility evaluates potential implications and develops appropriate response strategies to ensure business continuity and compliance.
Client Concentration and Client Restructuring Risks \u2022 A significant portion of revenue is concentrated among a few large clients, with the top 10 client groups contributing 83.9% of total revenue. \u2022 Sagility is actively diversifying its revenue base by strengthening capabilities across both, payer and provider segments. Within payers, Sagility is expanding into higher-value clinical services and patient support offerings for pharmacy benefit managers and specialty pharmacy players. Within the provider segment, it continues to scale end-to-end Revenue Cycle Management capabilities.
\u2022 Client overlaps within the sector, including consolidation, mergers, acquisitions or restructuring among healthcare payers and providers, may result in vendor rationalization, contract renegotiation, volume reallocation or pricing pressure. \u2022 While the payer segment remains largely consolidated, Sagility serves 7 of the Top 10 payers. Sagility maintains long-standing relationships with leading payers, supported by multi-year contracts, performance- linked contracts that provide revenue visibility. These relationships are further reinforced through deep operational integration, multiple stakeholder touchpoints, and long-standing engagement models.
\u2022 Acquisition of BroadPath represents a strategic step towards entering the mid and small-market segment, and broadening the client base and service portfolio. In parallel, Sagility is increasing integration within client workflows through proprietary platforms, strengthening client stickiness and increasing switching costs.
\u2022 Sagility maintains a proactive approach to restructuring risks, including continuous monitoring of client-specific developments and industry signals. During periods of consolidation or M&A, it actively engages with clients to ensure transition continuity and protect revenue streams.
Risk Theme Description Mitigation
Risk of Fluctuations in Client Business Volumes \u2022 Sagility\u2019s revenues are linked to client-driven transaction volumes across payer and provider operations. These volumes may fluctuate due to factors such as membership trends, cost pressures, regulatory changes, outsourcing decisions, or strategic reprioritization by clients. \u2022 Sagility mitigates volume variability through a combination of diversified revenue streams, flexible operating models, and contract structures aligned to client demand.
\u2022 Risk of insourcing of the work by the clients \u2022 Multi-year engagements and outcome-based commercial constructs provide revenue visibility, while expansion across clients, service lines, and segments reduces dependence on any single volume driver.
\u2022 Such variability may affect revenue predictability, capacity utilization, and operating leverage. \u2022 Sagility also maintains operational flexibility through dynamic workforce management, cross-trained talent pools, and multi-geo, scalable delivery infrastructure, enabling efficient alignment of capacity with demand.
\u2022 In addition, continuous client engagement and pipeline visibility support proactive planning and early response to volume changes.
\u2022 Together, these measures strengthen operational integration and client dependence on Sagility\u2019s platforms and delivery model, reducing the likelihood of insourcing and supporting long-term engagement stability.
Competition Risk \u2022 Sagility operates in an evolving market, with competition from global outsourcing providers, broad- based IT and business services firms, as well as specialized healthcare-focused companies. \u2022 Sagility differentiates through an integrated, domain-led operating model that combines deep healthcare expertise with technology, analytics, and platform-led delivery. It continues to shift toward outcome-based and managed services constructs that align more closely with client objectives, enabling value-led engagements rather than price-led competition.
\u2022 In addition, clients continue to enhance in-house capabilities and explore digital-led operating models, further intensifying competitive dynamics. \u2022 Competitiveness in bids is enhanced through structured deals that prioritize multi-year value creation over short-term returns, along with a continued expansion of non-linear, output-based commercial models. Expansion into higher-value clinical and adjacent service lines, along with platform integration within client workflows, further strengthens differentiation and increases switching barriers.
\u2022 This competitive intensity, along with clients continued focus on cost efficiency, results in evolving commercial constructs and pricing dynamics. \u2022 In parallel, Sagility leverages proactive geo-shifts and a multi- shore delivery model to optimize cost structures and enhance competitiveness, while long-standing client relationships and cross- sell opportunities support deeper engagement and sustained growth.
\u2022 Financial discipline is maintained through regular monitoring of account margins, with periodic reporting to leadership ensuring transparency and sustained profitability.
Cybersecurity and Information Security \u2022 Sagility handles sensitive health information and is exposed to risks arising from potential data breaches. \u2022 Sagility has established a robust cybersecurity framework, supported by advanced security capabilities including encryption, identity management, access controls, and network protection systems to safeguard sensitive data.
\u2022 Non-compliance with stringent U.S. data protection regulations, including HIPAA, HITECH, and CCPA, may result in regulatory action and reputational impact. \u2022 Cybersecurity controls are continuously strengthened through periodic risk assessments, vulnerability testing, and independent external reviews.
\u2022 Ongoing training and awareness programs help embed security awareness across the organization. \u2022 Sagility also maintains market-benchmarked cyber insurance coverage to mitigate potential financial exposure arising from cyber incidents.
Risk Theme Description Mitigation
Talent Management and Attrition (Including Succession Planning) \u2022 Elevated attrition and continued wage inflation tend to impact service continuity, cost structures, and margin profile. \u2022 Sagility maintains competitive, market-aligned compensation and benefits programs to attract and retain talent.
\u2022 Sagility operates in a competitive talent market, which may affect its ability to attract and retain skilled professionals across key roles. \u2022 Workforce capability is strengthened through structured hiring, training, and continuous skill development initiatives.
\u2022 Sagility also relies on deep domain expertise and long-standing client relationships managed by senior leadership; attrition at key management levels may affect client confidence and continuity of service. The Company continues to invest in employee engagement through ongoing programs and periodic satisfaction surveys, enabling early identification of improvement areas.
Succession planning is embedded within leadership management processes, with defined pipelines and structured talent mapping for key roles. These are supported by detailed Talent Cards capturing performance, aspirations, mobility, and development priorities.
ESG \u2022 Environmental, Social and Governance (ESG) considerations continue to gain importance, with increasing expectations from regulators, investors, and clients around sustainable, responsible, and ethical business practices. \u2022 Sagility has established a comprehensive ESG management framework aligned with global reporting standards, enabling structured monitoring and continuous improvement across operations. ESG considerations are embedded into business processes and decision-making, supporting alignment with evolving stakeholder expectations.
\u2022 Sagility\u2019s ability to effectively manage ESG priorities remains important to meeting stakeholder expectations and supporting long- term value creation. \u2022 Governance and oversight are strengthened through Board-level supervision, including a dedicated Corporate Social Responsibility and Sustainability Committees.
\u2022 Sagility has adopted Business Responsibility and Sustainability Reporting (BRSR), a recognized ESG disclosure framework in India applicable to India\u2019s top 1,000 listed companies (by market capitalization).
Inability to Scale Technology / AI Adoption \u2022 Clients across payer and provider segments are increasingly prioritizing measurable outcomes in areas such as cost optimization, automation, and member engagement, supported by technology-led solutions. \u2022 Sagility\u2019s technology strategy is anchored in a structured roadmap aligned to evolving industry needs, with defined milestones and disciplined execution. Capability building is further accelerated through targeted acquisitions focused on AI and emerging technologies.
\u2022 Sagility\u2019s ability to effectively scale AI-led solutions - while ensuring accuracy, safety, and compliance, remains important to delivering consistent outcomes and sustaining competitiveness. \u2022 A dedicated Go-to-Market Technology function works closely with Business Excellence and Delivery teams to design, deploy, and scale tech- & AI-led solutions across workflows. This is complemented by strategic partnerships that combine platform capabilities with Sagility\u2019s domain expertize.
\u2022 Rapid advancements in technology also require continuous evolution of platforms and tools to remain relevant and aligned with client expectations. \u2022 Continuous monitoring of client technology priorities and adoption trends enables early identification of shifts and timely alignment of solutions.
\u2022 Investments in proprietary platforms and AI capabilities, including BirchAI, healthcare-focused LLMs, and automation-led solutions, are strengthening Sagility\u2019s ability to deliver scalable, outcome-driven services.
\u2022 Ongoing focus on responsible AI deployment, including governance, testing, and guardrails, supports reliable and compliant adoption at scale.
Risk Theme Description Mitigation
NonCompliance to Data Privacy Regulations / Data Breach Sagility processes significant volumes of protected health and personal data, making data privacy and security a critical priority. Sagility enforces a Global Privacy Policy aligned with HIPAA, CMS, OIG, and international data protection laws. Oversight is led by a Legal & Compliance Officer.
Evolving regulatory requirements and client expectations, including standards such as HIPAA, HITECH, and related frameworks, require continuous strengthening of data protection practices. Regulatory requirements are mapped into GRC tools with assigned owners, while an operational risk register tracks project-level risks and mitigation measures.
\u2022 Robust device and access controls remain essential to prevent unauthorized access and ensure compliance with client and regulatory standards Privacy vigilance is strengthened through violation detection platforms, with third-party filtering and Compliance Team review ensuring swift corrective action. Key platforms maintain HITRUST i1 certifications to reinforce trust.
Annual training programs in Infosec and CMS compliance keep the employees, contractors, and vendors informed and accountable.

INTERNAL CONTROL SYSTEMS AND THEIR ADEQUACY

Sagility believes that a strong internal control framework is fundamental to ensuring the orderly and efficient conduct of its business operations and safeguarding stakeholder interests. Accordingly, we have established robust and adequate internal control systems and procedures, commensurate with business requirements, scale of operations, geographical presence, and regulatory obligations. These systems encompass well-defined policies and procedures, integrated IT systems, clearly articulated delegation of authority, appropriate segregation of duties, and a comprehensive internal audit and review framework.

Sagility has also implemented effective internal financial controls designed to ensure adherence to established policies, protection of its assets, prevention and detection of fraud and errors, accuracy and completeness of accounting records, and the timely preparation of reliable financial information.

The Board is assisted in its oversight responsibilities by an internal audit function. PricewaterhouseCoopers Services LLP serves as the Internal Auditor as of 31 st March 2026. The internal audit function conducts both periodic and need-based reviews of risk management systems, controls, and processes.

The findings, along with recommendations, are presented to the Board and Audit Committee, and appropriate corrective actions are undertaken to strengthen the control environment. Further, Sagility has adopted a structured framework of delegation of authority and segregation of duties across its operations. This framework is designed to provide reasonable assurance with respect to the integrity and reliability of financial and operational information, compliance with applicable laws and regulations, and execution of transactions with appropriate authorization, thereby reinforcing the overall governance and control environment.

CAUTIONARY STATEMENT

Thisdocumentcontainsforward-lookingstatementsthatinvolve risks, uncertainties, and assumptions, which may include but are not limited to statements regarding the Companys business strategy, future operations, expected financial position, and anticipated developments in the industry. These statements are based on current expectations, estimates, and projections and are not guarantees of future performance. Actual results may differ materially due to various factors, including changes in regulatory environments, market conditions, competitive pressures, operational risks, client decisions, and economic conditions.

Knowledge Center
Logo

Logo IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000

Logo IIFL Capital Services Support WhatsApp Number
+91 9892691696

Download The App Now

appapp
Loading...

Follow us on

facebooktwitterrssyoutubeinstagramlinkedintelegram

2026, IIFL Capital Services Ltd. All Rights Reserved

ATTENTION INVESTORS

RISK DISCLOSURE ON DERIVATIVES

Copyright © IIFL Capital Services Limited. All rights Reserved.

IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132 (Member ID - NSE: 10975 BSE: 179 MCX: 55995 NCDEX: 01249), DP SEBI Reg. No. IN-DP-185-2016, Merchant Banker SEBI Regn. No. INM000010940, RA SEBI Regn. No: INH000000248, BSE Enlistment Number (RA): 5016, AMFI-Registered Mutual Fund Distributor & SIF Distributor
ARN NO : 47791 (Date of initial registration – 17/02/2007; Current validity of ARN – 08/02/2027), PFRDA Reg. No. PoP 20092018, IRDAI Corporate Agent (Composite) : CA1099

ISO certification icon
We are ISO/IEC 27001:2022 Certified.

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.